Serum receives purchase order from Govt. of India
The Serum Institute has revealed that it has received the purchase order from Indian Govt. to procure 11 million doses of the COVID-19 vaccine and it will also be manufacturing Oxford-AstraZeneca’s, Covishield in India which will be available for Rs. 200 per vial.
The distribution process will begin from Jan 11 and the handling/distribution of Covishield from Serum’s Pune based facility will be done at Mumbai airport while Pune airport will handle 40-45% of the order.